Tech giants are exploring new ways to address the age problem.
Time’s new cover features a wide-eyed toddler with the headline “This baby could live to be 142 years old.” The article declares, “An American born today has a projected average lifespan 20 full years longer than one born in 1925, and we are, as a society, growing old.”
Bloomberg this month reported on “The Forever Pill,” an attempt from Novartis to create the first anti-aging drug. This echoes what we covered in the Future 100 report—the idea that Silicon Valley’s latest endeavor is tackling aging.
“We could be doing a lot more in the fight against aging,” PayPal co-founder Peter Thiel said at the 2014 Web Summit in Dublin during his interview with Financial Times editor Caroline Daniel, pointing to a rising theme in Silicon Valley. “It’s a problem that could be slowed. We could figure out what causes it, how to reverse it. Almost every disease in the world is linked to aging: We have a 1 in 1,000 chance of getting cancer in the next year at age 30, and a 1 in 10 chance at age 80. Almost everything is like that.”
Tech giants are exploring ways to address the age problem. Google is backing Calico, a biotech company focused on health and well-being, particularly in relation to aging and associated diseases. Explained Google CEO Larry Page: “Illness and aging affect all our families. With some longer term, ‘moonshot’ thinking around health care and biotechnology, I believe we can improve millions of lives.” In September 2014, the company announced a new facility to research diseases that often affect the elderly.
Are we really headed for a 142-year life span? And what will it look like?
Image Credit: Time Inc.